Table 2.
Antimicrobial susceptibility pattern of bacterial isolates from blood culture of febrile patients at Mekelle hospital, Northern Ethiopia (March–October 2014) no. (%)
| Organism | Bacterial isolates resistant to each drug tested (%) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| AMC | CRO | CN | DO | CIP | SXT | E | OX | NOR | F | |
| S. aureus | 7 (13) | 31 (57.4) | 18 (33.3) | 29 (53.7) | 21 (38.9) | 36 (66.7) | 24 (44.4) | 38 (70.4) | 18 (33.3) | NA |
| CoNS | 5 (11.4) | 22 (50) | 8 (18.1) | 27 (61.4) | 11 (25) | 36 (81.8) | 18 (40.9) | 27 (61.4) | 13 (29.5) | NA |
| S. pyogenes | 1 (16.7) | 1 (16.7) | 0 | 4 (66.7) | 1 (16.7) | 5 (83.3) | 1 (16.7) | 0 | 1 (16.7) | NA |
| E. coli | 1 (6.7) | 9 (60) | 2 (13.3) | 6 (40) | 1 (6.7) | 10 (6.7) | NA | NA | 9 (60) | 4 (26.7) |
| Citrobacter spp. | 2 (25) | 4 (50) | 2 (25) | 4 (50) | 1 (12.5) | 3 (37.5) | NA | NA | 6 (75) | 1 (12.5) |
| Acinetobacter spp. | 1 (20) | 4 (80) | 0 | 2 (40) | 0 | 3 (60) | NA | NA | 2 (40) | 0 |
| S. typhi | 0 | 3 (37.5) | 2 (25) | 4 (50) | 1 (12.5) | 4 (50) | NA | NA | 6 (75) | 2 (25) |
| S. paratyphi | 0 | 1 (50) | 1 (50) | 1 (50) | 1 (50) | 1 (50) | NA | NA | 1 | 1 (50) |
| Klebsiella spp. | 0 | 0 | 0 | 0 | 0 | 0 | NA | NA | 1 (100) | 1 (100) |
| P. mirabilis | 0 | 0 | 0 | 0 | 0 | 0 | NA | NA | 0 | 1 (100) |
| P. aeruginosa | 0 | 0 | 1 (100) | 1 (100) | 0 | 0 | NA | NA | 0 | 0 |
| Total | 17 (11.8) | 75 (52) | 34 (23.6) | 78 (54.2) | 37 (25.7) | 89 (61.8) | 45 (31.3) | 65 (62.5) | 56 (38.9) | 10 (22.2) |
AMC amoxicillin clavulanic acid, CRO ceftriaxone, CN gentamicin, DO doxycycline, CIP ciprofloxacin, SXT trimethoprim-sulphamethoxazole, E erythromycin, OX oxacillin, NOR norfloxacin, F Nitrofurantonin, NA not applicable.